Evofem Biosciences Inc. buy krebskrebs
Start price
22.03.21
/
50%
€34.73
Target price
22.03.22
€52.50
Performance (%)
-84.26%
End price
23.03.22
€5.47
Summary
This prediction ended on 23.03.22 with a price of €5.47. Massive losses of -84.26% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evofem Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% | 43.350% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% | 72.418% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% | 43.435% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% | 54.983% |
Comments by krebskrebs for this prediction
In the thread Evofem Biosciences diskutieren
In the thread Trading Evofem Biosciences
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten